Adiponectin and NT-proBNP are implicated in the pathogenesis and pathophysiology of CAD, for example, low levels of adiponectin (< 4.0 μg/mL) have been reported to be associated with an increased risk of CAD43. This evidence concerns the gene NPPB and coronary artery disorder.